Viking Therapeutics' Stock Pops on News of Positive Data From Trial of Treatment for Rare Metabolic Disorder X-ALD
Viking Therapeutics' Stock Pops on News of Positive Data From Trial of Treatment for Rare Metabolic Disorder X-ALD
viking therapeutics股票因罕见代谢性疾病X-ald治疗试验的积极数据消息而上涨
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间